Indeed, our data on HDAC-induced cone protection at different stages of rd1TN-XL cone loss (PN19 and PN21) confirm this and is furthermore in line with other observations indicating that the window-of-opportunity for the treatment of retinal dystrophies is much broader than it is currently considered [2, 49]. This evidence concerns the gene HDAC9 and Retinal dystrophy.